Chronic Kidney Disease Treatment

Although there is no cure for chronic kidney disease (CKD), it is important that measures are taken to prevent or slow down progression, even in early stages of the disease, as this can help to prevent end-stage kidney failure.

The management of stage 1-3 of chronic kidney disease primarily involves monitoring for progression of the disease and does not usually require specialist attention. For more severe cases or individuals with stage 4 or 5 CKD, referral to a specialist for help in making the treatment decisions may be beneficial.

Aim of Treatment

The primary treatment aims for chronic kidney disease are to:

  • Prevent or slow the progression of the disease
  • Relieve any symptoms associated with the condition

If there is an underlying health condition that is responsible for causing the disease, such as hypertension or diabetes, this should be managed first and an improvement in kidney function is likely to be seen following this.

It is also important that affected individuals are aware that CKD can increase their risk of developing hypertension and cardiovascular disease. For this reason, they should be advised of ways to reduce their risk of the disease, including lifestyle modifications and pharmacological interventions.

Managing Underlying Conditions

Several health conditions may be responsible for causing CKD and these should be identified and managed in an appropriate manner to lessen the load on the kidneys and progression of the disease. This may include:

  • Diabetes: pharmacological intervention to control blood sugar
  • Hypertension: diet, lifestyle and pharmacological intervention to lower blood pressure to less than 130/80 mmHg
  • Recurring UTI: prophylactic antibiotics to prevent infection
  • Urinary obstruction: surgery to remove obstruction

Slowing Progression of Disease

Chronic kidney disease tends to slowly worsen over time, even when treatment methods for any underlying causes are in place. For this reason, it is important that regular tests are employed to monitor the kidney function and disease progression.

A review of other medications is useful to identify potential causes of progression, such as lithium or non-steroidal anti-inflammatory drugs (NSAIDS) that are usually avoided. As the renal function decreases, the ability of the body to excrete renally cleared drugs can become compromised and should be avoided.

Some medications such as angiotensin-converting enzyme (ACE) inhibitors can have a protective effect on the function of the kidneys and slow the progression of the disease, in addition to reducing the risk of cardiovascular disease.

Reducing Cardiovascular Disease Risk

Patients with CVD are more likely to be affected by heart disease, stroke and peripheral artery disease. This often includes an array of medications to control blood pressure, cholesterol and blood glucose. It is also essential to make lifestyle modifications that help to reduce cardiovascular risk such as:

  • Quitting smoking
  • Reducing alcohol intake
  • Increasing fruits and vegetables in diet
  • Limiting salt intake
  • Keeping physically active

Symptomatic Relief

In severe cases of CKD, symptoms can present and may require medical management. For example, fatigue from anemia can be improved with administration of iron or erythropoietin.

The diet can also have a significant impact on the kidney function and the severity of symptoms for those affected. It is usually advised to reduce the intake of salt and the fluid consumption may also be controlled in some cases.


Patients with stage 3 or higher CKD should receive an annual vaccination to offer protection against infections such as influenza, in addition to a once-off pneumococcus immunization. Those with stage 4 CKD should also be immunized against hepatitis B.

End-Stage Kidney Failure

For patients with stage 5 CKD, the function of the kidneys is significantly compromised and cannot usually keep up with daily demands. For this reason, patients will often require kidney dialysis or a transplant to survive.


Further Reading

Last Updated: Aug 23, 2018

Yolanda Smith

Written by

Yolanda Smith

Yolanda graduated with a Bachelor of Pharmacy at the University of South Australia and has experience working in both Australia and Italy. She is passionate about how medicine, diet and lifestyle affect our health and enjoys helping people understand this. In her spare time she loves to explore the world and learn about new cultures and languages.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Smith, Yolanda. (2018, August 23). Chronic Kidney Disease Treatment. News-Medical. Retrieved on September 29, 2022 from

  • MLA

    Smith, Yolanda. "Chronic Kidney Disease Treatment". News-Medical. 29 September 2022. <>.

  • Chicago

    Smith, Yolanda. "Chronic Kidney Disease Treatment". News-Medical. (accessed September 29, 2022).

  • Harvard

    Smith, Yolanda. 2018. Chronic Kidney Disease Treatment. News-Medical, viewed 29 September 2022,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
What is the risk of SARS-CoV-2 infection among gout patients?